Showing results (1201-1210 of 2,366) with videos related to

Sort By:
Pageof 237
Future Medicinal Chemistry|July 2, 2015
Progress in the research of GPIIb/IIIa antagonistsZhouling Xie, Chen Cao, Sen Feng, et al.
Future Medicinal Chemistry|July 7, 2015
N-heterocyclic carbene metal complexes as bio-organometallic antimicrobial and anticancer drugsSiddappa A Patil, Shivaputra A Patil, Renukadevi Patil, et al.
Future Medicinal Chemistry|July 7, 2015
Transcriptional analysis reveals distinct subtypes in amyotrophic lateral sclerosis: implications for personalized therapyGiovanna Morello, Sebastiano Cavallaro
Future Medicinal Chemistry|June 11, 2015
Pyranopyrazolotacrines as nonneurotoxic, Aβ-anti-aggregating and neuroprotective agents for Alzheimer's diseaseMourad Chioua, Javier Pérez-Peña, Nuria García-Font, et al.
Future Medicinal Chemistry|June 11, 2015
Searching phase II enzymes inducers, from Michael acceptor-[1,2]dithiolethione hybrids, as cancer chemopreventive agentsMarcos Couto, Stefani de Ovalle, Mauricio Cabrera, et al.
Future Medicinal Chemistry|June 11, 2015
Drugging ATR: progress in the development of specific inhibitors for the treatment of cancerKevin M Foote, Alan Lau, J Willem M Nissink
Future Medicinal Chemistry|June 11, 2015
Microwave-assisted synthesis of chromenes: biological and chemical importanceShivaputra A Patil, Siddappa A Patil, Renukadevi Patil
Future Medicinal Chemistry|June 11, 2015
Recent advances in research of natural and synthetic bioactive quinolinesPo-Yee Chung, Zhao-Xiang Bian, Ho-Yuen Pun, et al.
Future Medicinal Chemistry|June 13, 2015
Beyond cyclosporine A: conformation-dependent passive membrane permeabilities of cyclic peptide natural productsChristopher L Ahlbach, Katrina W Lexa, Andrew T Bockus, et al.
Future Medicinal Chemistry|June 12, 2015
Rational drug design, synthesis and biological evaluation of dihydrofolate reductase inhibitors as antituberculosis agentsNilesh R Tawari, Seema Bag, Archana Raju, et al.
Pageof 237